Crawford & Co(CRD-B) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 24.9 | EPS (ttm) | 0.47 | Insider Own | 87.56% | Shs Outstand | 18.9M | Perf Week | -3.2% |
| Market Cap | 0.59B | Forward P/E | 10.45 | EPS next Y | 7.28% | Insider Trans | -2.45% | Shs Float | 5.9M | Perf Month | -2.48% |
| Enterprise Value | 0.78B | PEG | - | EPS next Q | 0.31 | Inst Own | 10.32% | Short Float | 0.15% | Perf Quarter | 9.35% |
| Income | 0.02B | P/S | 0.45 | EPS this Y | 15.75% | Inst Trans | - | Short Ratio | 0.96 | Perf Half Y | 22.89% |
| Sales | 1.31B | P/B | 3.07 | EPS next 5Y | - | ROA | 3.02% | Short Interest | 0.01M | Perf YTD | 10.17% |
| Book/sh | 3.84 | P/C | 7.94 | EPS past 3/5Y | - -5.79% | ROE | 12.95% | 52W High | -13.1% ($13.59) | Perf Year | 16.01% |
| Cash/sh | 1.49 | P/FCF | 6.23 | Sales past 3/5Y | 2.18% 5.27% | ROIC | 6.16% | 52W Low | 34.51% ($8.78) | Perf 3Y | 29.35% |
| Dividend Est. | $0.31 (2.62%) | EV/EBITDA | 6.64 | EPS Y/Y TTM | -20.24% | Gross Margin | 27.3% | Volatility(W/M) | 4.64% 4.81% | Perf 5Y | 28.65% |
| Dividend TTM | 0.3 | EV/Sales | 0.6 | Sales Y/Y TTM | -4.12% | Oper. Margin | 5.96% | ATR (14) | 0.58 | Perf 10Y | 6.11% |
| Dividend Ex-Date | - | Quick Ratio | 1.19 | EPS Q/Q | 76.14% | Profit Margin | 1.8% | RSI (14) | 51 | Recom | 1 |
| Dividend Gr. 3/5Y | 6.51% 11.27% | Current Ratio | 1.19 | Sales Q/Q | -1.38% | SMA20 | -1.81% ($12.03) | Beta | 0.62 | Target Price | $14.5 |
| Payout | 73.72% | Debt/Eq | 1.45 | Earnings | 2026/8/3 | SMA50 | 5.24% ($11.22) | Rel Volume | 1.65 | Prev Close | $11.64 |
| Employees | 9943 | LT Debt/Eq | 1.05 | EPS/Sales Surpr. | 46.15% -3.92% | SMA200 | 12.7% ($10.48) | Avg Volume(3M) | 0.01M | Price | $11.81 |
| IPO | 1980/3/17 | Option/Short | No/Yes | Trades | 104 | Volume | 15,270 | Change | 1.46% |
Company
CRD-B is a Financial sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🏢 Crawford & Company is a US-based company that provides loss adjusting and claims management, as well as outsourcing services, to insurance companies, self-insured organizations, and government agencies. It belongs to a global leading group in the independent claims management sector and operates a business model that, positioned at the back end of the property and casualty insurance value chain, handles accident investigation, evaluation, and claims settlement on behalf of its clients.
Over the past 1 year, roughly in the middle
13% below its 1-year high.
CRD-B makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +15.8% this year.
Tap to view numbers
The price looks about right
Trading at 24.9 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by +29.4% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 2.62% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 10.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
AIMS 0.00%
DGRS 0.00%
IWC 0.00%
EES 0.00%
AVTM 0.00%It ranks #4 in the industry
Based on market cap of $586M.
CRD-B $586M PER 24.9
MRSH $84B PER 21.6
AON $62B PER 16.7
AJG $62B PER 39.8
FAQ
What kind of company is CRD-B?
CRD-B belongs to the Financial sector and operates in the Insurance Brokers industry.
What is the market cap of CRD-B?
The market cap of CRD-B is approximately $586M, ranking 3,099 within its sector.
Does CRD-B pay dividends?
CRD-B has a dividend yield of approximately 2.62%, with an annual dividend of $0.31.
What is the P/E ratio of CRD-B?
CRD-B has a P/E ratio of approximately 24.9x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for CRD-B?
CRD-B has recorded a 52-week high of $13.59 and a low of $8.78.
